BioSpace News Archive

Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, focused on delivering first-in-class biological therapies that have the potential to transform the lives of people with serious diseases, today announces that it has dosed the first patient in a Phase I study, part of an ongoing collaboration with GlaxoSmithKline (GSK).

Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing System received the approval certificate from the China National Drug Administration (CNDA).

The Alzheimer’s Research and Prevention Foundation (ARPF) announced today that Elissa Epel, Ph.D of the University of California San Francisco is giving the keynote address at their second annual Brain Longevity Therapy Training on October 12-14, 2018 in Washington, DC

Repro-Med Systems, Inc., dba RMS Medical Products (OTCQX: REPR) today announced that Chairman and Interim President and Chief Executive Officer Dan Goldberger will be presenting at the 7th annual Liolis Gateway Conference taking place September 5-6, 2018

Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 - 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.

CStone Pharmaceuticals (CStone) announced today that its IND application for CS1002, an investigational cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) monoclonal antibody, has been approved by the China National Drug Administration (CNDA).

To expand its suite of information technology quality and compliance solutions for life sciences organizations, Deloitte has acquired QSpace

Restaurant Marks Childhood Cancer Awareness Month with “Round-Up” Campaign

Adaptive Health is excited to announce the company was awarded three of the six GNC Vendor Awards at the 2018 annual GNC Global Franchise Convention in Las Vegas, Nevada.

Dr. Andrew Rosenstein to Assume Interim CEO Role Funds To Increase Focus on Lab Testing Operations and California Market Opportunity